| Keynote | ||
| Moderator: Andrea Doria (Italy) | ||
| Understanding and treating SLE: A new era is dawning Recorded Q&A (15 Mins) | Ronald van Vollenhoven (Netherlands) | |
| Debate: New Developments in Basic Science and Clinical Research: Defining SLE | ||
| Moderator: Ricard Cervera (Spain) | ||
| The matter of the debate | Ricard Cervera (Spain) | |
| A majority of lupus patients (will) need a biologic! | David Isenberg (UK) | |
| A minority of lupus patients (will) need a biologic! | Murray Urowitz (Canada) | |
| Recorded Voting, Q&A and Discussion (20 Mins) | All | |
| Hot Topic | ||
| Moderators: Murray Urowitz (Canada), David Isenberg (UK) | ||
| Optimal assessment and monitoring of SLE patients in clinical practice Recorded Q&A (10 Mins) | Alexandre Voskuyl (Netherlands) | |
| State-of-the-art | ||
| Moderators: Bevra Hahn (USA), Sandra Navarra (Philippines) | ||
| Diagnosis and treatment of neuropsychiatric lupus Q&A (10 Mins) | Marcello Govoni (Italy) | |
| Covid-19 and SLE – What do we know today? Q&A (10 Mins) | Fabrizio Conti (Italy) | |
*Please note that this session (presentation and discussion) is pre-recorded and there will not be an opportunity to participate in discussion.